Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-08

Clinical Trial Update: Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder

View source ↗

Summary

Clinical Trial Update notes that a single-patient study evaluating vancomycin with fecal microbiota transplant for Autism Spectrum Disorder is no longer availab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplant (fecal microbiota transplant)
  • Vancomycin (vancomycin)

Snippet

Sponsor: ProgenaBiome | Conditions: Autism Spectrum Disorder, Autism | Status: NO_LONGER_AVAILABLE